Loading clinical trials...
Loading clinical trials...
The Effect of Gender-affirmative Measures on Breast Perception in Trans Men (TRANSBREAST) - a Prospective Cohort Study
Breast dysphoria in transmasculine or genderdiverse individuals is a distinct psychological burden associated with depression, anxiety and suicidality. The aim is to systematically investigate the effect of GAHT (gender-affirming hormone therapy) and mastectomy on this form of dysphoria. The primary objective of this study is to analyse and investigate the psychological and physical effects of breast development on trans men or genderdiverse individuals. A secondary objective is to determine the extent to which the stress affects the well-being of trans men depending on the coping strategies used (binding vs. taping).
Age
16 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Medical University Innsbruck
Innsbruck, Austria
Start Date
November 30, 2025
Primary Completion Date
November 1, 2030
Completion Date
November 1, 2030
Last Updated
March 6, 2026
100
ESTIMATED participants
quality of life questionnaire- iTransQoL, chest dysphoria measure
OTHER
Lead Sponsor
Medical University Innsbruck
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06487754